ArticleMedicine2015
Primary Multiple Pulmonary Primitive Neuroectodermal Tumor: Case Report and Literature Review.
Article in Medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 16 citations in OpenAlex.
- Primary Ewing Sarcoma of the Lung: Integrative Analysis of Clinical, Histopathological, Immunohistochemical, and Cytogenetic Features with Literature Review.Indian journal of surgical oncology · 2026Article
- A rare radiotherapy-sensitive primitive neuroectodermal tumor withThe Journal of international medical research · 2022Review
- Peripheral primitive neuroectodermal tumor: a case report.Journal of medical case reports · 2022Article
- Primary pulmonary Ewing's sarcoma: rare cause of massive hemothorax in a young girl-case report.BMC pediatrics · 2021Article
- Rare Primary Pulmonary Primitive Neuroectodermal Tumor: A Case Report and Literature Review.OncoTargets and therapy · 2021Article
- Primary pulmonary Ewing sarcoma/peripheral primitive neuroectodermal tumor.Proceedings (Baylor University. Medical Center) · 2020Article
- Primary Ewing's sarcoma of the lung: a rare case report.Indian journal of thoracic and cardiovascular surgery · 2020Article
- Antiangiogenic therapy for primitive neuroectodermal tumor with thalidomide: A case report and review of literature.Medicine · 2017Review
- Recurrent spinal primitive neuroectodermal tumor with brain and bone metastases: A case report.Medicine · 2017Article
- Benefit of Sunitinib in the treatment of pulmonary primitive neuroectodermal tumors: a case report and literature review.Oncotarget · 2016Review
- Primitive neuroectodermal tumor originating from the lung: A case report.Oncology letters · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Primitive neuroectodermal tumors (PNETs) arising directly from the lung are extremely rare but particularly aggressive neoplasms. Although thoracic PNET usually develops on the chest wall, there have been reports of primary Ewing sarcoma/PNET of the lung.We present the case of a 16-year-old male with PNET diagnosed following histologic and immunohistochemical examination of a video-assisted thoracic surgical biopsy. As typically occurring for these tumors, the diagnosis was initially delayed in our patient and prognosis was poor despite aggressive surgical resection and postoperative chemotherapy. We attempted to explore the use of targeted pharmacotherapy through high-throughput sequencing in this case. We found that this treatment using Avastin and Cetuximab could provide a new therapeutic direction for PNET.PNENTs arising from the lung parenchyma without pleural or chest wall involvement are extremely rare. Although uncommon, if the pathological features are similar to Ewing sarcoma, PNENTs should be kept in mind, and the target therapy may be a potent treatment for this disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.